The expression of the serotonin (5-HT) receptors 5-HT1AR, 5-HT2AR and 5-HT3R was investigated in allergic contact eczematous human skin by an indirect fluorescence method. 5-HT1AR expression was found in basal epidermal NK1-beteb-positive cells, which were more elongated and showed longer dendritic processes in contact eczematous skin than in control skin. Immunoreactivity for 5-HT1AR was also found in the upper part of the epidermis, with no difference between eczematous and control skin. 5-HT1AR expression was also found in 33.3±6.5% and 63.7±11.3% of papillary dermal mononuclear cells in inflamed skin and control skin, respectively (P<0.001), as well as in vessel walls. Some of these mononuclear cells were tryptase-positive, and found in both eczematous and control skin. 5-HT2AR-positive cells were found in the upper part of the epidermis in eczematous skin, but were more evenly distributed in the epidermis of control skin. In addition, inflammatory dermal mononuclear cells and vessel walls showed immunoreactivity for this receptor. 5-HT3R expression was found in the basal epidermal layer of eczematous and control skin. These findings indicate a plasticity in the effects of serotonin, especially regarding 5-HT1AR, in allergic contact eczematous skin.
Introduction
Serotonin (5-hydroxytryptamine, 5-HT) is a monoamine acting as a neuromediator in the central and peripheral nervous systems. It is also a vasoactive amine which is stored in the blood by platelets and released at sites of inflammation. It has a wide range of actions on T cells and other effector cells in vitro and in vivo [1, 2] . In vivo treatment of skin-sensitized mice with ketanserin, a 5-HT2 receptor antagonist, inhibits their capacity to elicit a delayed-type hypersensitivity (DTH) reaction and also the ability of their lymphoid cells to transfer DTH [3] . Spi perone [4] , a neuroleptic able to antagonize the 5-HT receptors 5-HT1AR and 5-HT2AR, and buspirone [5] , a 5-HT1AR agonist, have been shown to inhibit delayed cutaneous hypersensitivity in mice. Of the different tested serotonin antagonists, ketanserin has been shown to have an inhibitory effect on the established [6] but not the challenge [7] phase of allergic contact dermatitis in humans. These studies suggest that serotonin contributes to the hypersensitivity response.
We have previously found increased levels of 5-HT in contact eczematous human skin compared to control skin [8] . There was also a 5-HT-like immunoreactivity in melanocyte-like cells in the epidermis of the control and inflamed contact eczematous skin.
The wide variety of behavioural and physiological functions mediated by serotonin is reflected by its numerous receptor subtypes. As many as 14 different receptor subtypes have been cloned in mammals and these have been classified according to structural, transductional and functional criteria [9, 10, 11] . The receptors 5-HT1AR, 5-HT2AR and 5-HT3R are the best characterized of the 5-HT receptors (for references see reference 12).
In the present investigation, in order to further study the pathophysiological role of 5-HT in contact eczema, we investigated the expression of 5-HT receptors in human allergic contact eczematous skin using immunohistochemistry and antibodies to 5-HT1AR, 5-HT2AR and 5-HT3R, as well as markers for epidermal and dermal cells taking part in inflammatory processes in the skin.
Materials and methods

Biopsy specimens
Biopsy specimens were obtained from sites of positive (grade 3+) epicutaneous patch-test reactions (n=8) (graded according to the scoring system recommended by the International Contact Dermatitis Research Group) to 5% nickel sulphate (n=5), 0.5% cobalt chloride (n=2) and 25% Balsam of Peru (n=1), in petrolatum, and from control skin (n=7) from the contralateral side to the patch test reaction. The patch testing was performed using polypropylenecoated Finn chambers (Epitest, Helsinki, Finland) mounted on Scanpor (Norgesplaster, Oslo, Norway) for 72 h.
Processing the specimens
The specimens were fixed in phosphate-buffered 10% formalin with 0.2% picric acid for 1 h, rinsed in 0.1 M Sörensen's buffer containing 5% sucrose for at least 24 h, and sectioned on a Dittes cryostat (section thickness 14 µm). They were then processed for immunohistochemistry as described previously [13] .
lmmunohistochemical staining of 5-HT receptors Polyclonal antibodies to rat 5-HT1AR (SlA-170 and SlA-258) were raised in rabbits and used at a dilution of 1:1000. The antibodies are directed against amino acids 170-186 in the secondary extracellular loop and amino acids 258-274 in the third intracellular loop, respectively [14] . The amino acid sequence 170-186 shows complete homology between the human and rat, while the third intracellular loop shows considerable species difference. The percentages of 5-HT1A-positive cells out of 200 papillary dermal mononuclear round cells in eczematous and control skin was calculated and are expressed as the means±SD in four non-adjacent sections. A monoclonal antibody against 5-HT2AR was a generous gift from Pharmingen (San Diego, Calif.) and was used at a dilution of 1:150. A polyclonal antibody to human 5-HT3R [15] was used at a dilution of 1:2000, with a preimmune serum as control.
The antibody solutions were diluted in phosphate-buffered saline (PBS), pH 7.4, also containing sodium azide (0.01%) and bacitracin (0.01%). The sections were incubated with the primary antibodies overnight at 4ºC in a humid atmosphere, rinsed in PBS for 10 min with three changes. They were then incubated with a rhodamine-conjugated swine antirabbit antibody (dilution 1:40; Euro-Diagnostica, Malmö, Sweden) or a rhodamine-conjugated rabbit antimouse antibody (dilution 1:20; Dako, Copenhagen, Denmark) for 30 min at 37ºC. Controls with mouse IgG of the same isotype (Dako) and in the same dilution as the monoclonal antibody were negative. Controls omitting the primary antibodies were also negative. Preadsorption of the 5-HT1A antibody against the extracellular receptor was performed with the corresponding antigenic peptide which was synthesized by Ross-Petersen (Horsholm, Denmark) and used at a concentration of 0.1 mg/ml. Double staining of 5-HT1AR and melanocytes/inflammatory cells Sections were incubated with 10% normal horse serum for 15 min and then overnight at 4ºC with a monoclonal antibody against melanoma-associated antigen (dilution 1:80; NKI-beteb, Sanbio BY, Am Uden, The Netherlands), tryptase (dilution 1:5000; Chemicon, Temecula, Calif.), CD1a (1:50), HLA-DR (1:50), CD3 (1:40), CD4 (1:40) and CD8 (1:40) (all from Becton-Dickinson, Bedford, Mass.). Biotinylated horse antimouse IgG (dilution 1:200; Vector, Burlingame, Calif.) was used as a secondary antibody. In a third step the sections were incubated with streptavidinconjugated Texas Red (dilution 1:100; Vector). The sections were then allowed to react with 10% normal mouse serum for 60 min and then with 10% normal swine serum for 15 min followed by incubation overnight with the polyclonal antiserum against the extracellular 5-HT1AR. Swine anti-rabbit IgG (dilution 1:30; Dako) conjugated with fluorescein isothiocyanate (FITC) was used as a secondary antibody. Controls with mouse IgG of the same isotype (Dako) and in the same dilution as the monoclonal antibodies and omitting the 5-HT1AR antibody were all negative. Microscopy
The sections were coverslipped with glycerol/PBS (3:1) containing 0.1% p-phenylenediamine and examined with epifluorescence using a Nikon Microphot-FX microscope. The FITC-fluorescent structures were studied in a Nikon B-2A filter cube (excitation at 450-490 nm with a bandpass emission filter passing 520-560 nm) and the rhodamine-fluorescent structures with a Nikon G-1B filter cube (excitation at 546+5 nm with a barrier filter at 590 nm). Double staining was examined with Nikon/rhodamine double filter.
Photographs were taken on black-and-white Kodak TMax 400 pro film.
Statistics
Differences between groups were analysed using the Mann-Whitney U-test.
Results
Immunoreactivity for 5-HTlAR was seen in basal epidermal cells, which were round in shape, in control skin using the antibody against the extracellular receptor (Fig. 1a) , while no staining was found with the antibody against the intracellular receptor (not shown). Basal epidermal cells were more elongated, with longer dendritic processes, in contact eczematous skin (Fig. 1b) . With double staining there was a similar staining for the extracellular 5-HTIAR and NKI-beteb in basal epidermal cells (Fig. 2) . In control experiments, omitting the primary extracellular antibody or preadsorbing the antibody with the antigenic peptide, staining was abolished (Fig. 1c) .
Immunoreactivity for 5-HT1AR was also found in up to one-quarter of the width of the upper epidermis in both eczematous and control skin (Fig. 1a, b) with no difference between eczematous and control skin. Immunoreactivity for 5-HT1AR was also evident on the vessel walls and on round dermal cells. In contact eczematous skin and control skin, 33.3±6.5% and 63.7±11.3%, respectively, of inflammatory round cells in the papillary dermis showed immunoreactivity for 5-HTlAR, and the difference was statistically significant (P<0.001). Double staining showed some of these 5-HTlAR-positive cells to be tryptase-posi- tive, also with a dendritic appearance (Fig. 3) , while none of these cells were found to be positive for CDla, HLA-DR, CD3, CD4 or CD8 (not shown).
Immunoreactivity for 5-HT2AR was seen with the same intensity throughout the epidermis of control skin, as well as on the vessel walls and smooth muscle (Fig. 4a) . In inflamed skin, including the epidermis, it was found in the upper part of the epidermis (Fig. 4b) . In addition, dermal mononuclear inflammatory cells showed immunoreactivity for this receptor. In control experiments with this monoclonal antibody staining was not present (not shown).
Immunoreactivity for 5-HT3R was found in basal epidermal cells, and was more evident in the acrosyringium and in the epithelium of hair follicles, with no difference between contact eczematous and control skin (Fig. 5) . No epidermal immunoreactivity was found when preimmune serum was used. In addition, smooth muscle showed immunoreactivity (not shown).
Discussion
In the present study basal epidermal cells showed immunoreactivity for 5-HT1AR. Double staining showed these cells, which in contact eczematous skin were more elongated and had longer dendritic processes, to be melanocytes. In previous investigations [8, 16, 17] , it has been shown that melanocytes may contain 5-HT and thus we might be dealing with an autocrine system in which 5-HT may play an important role. The 5-HT1AR may be of importance for the participation of the melanocytes in the inflammatory process of contact eczema. Expression of 5-HT1AR has been found on migrating neural crest cells [18] . McEwan et al. [19] found that, in human melanoma cells, a 5-HT uptake inhibitor (6-nitro-quipazine) can inhibit melanization by suppressing the uptake of extracellular dopa.
5-HT immunoreactivity has been found in the epidermis of the earthworm Lumbricus terrestris [20] . The localization of 5-HT1AR immunoreactivity to the upper epidermis is interesting in view of the fact that serotonin immunoreactivity has also been found there [8] . This receptor may be of importance for normal differentiation of keratinocytes, as has been shown for neuronal cells [21] . There was a higher percentage of round dermal mononuclear cells positive for 5-HT1A in control than in inflammatory skin. The reason for this is not clear, but it may indicate that in control skin there is a delicate balance with the basal expression of this receptor. The increased number of 5-HT1A-positive cells in control skin might also indicate a lack of stimulation of the 5-HT1AR due to decreased activation [22] . In this context, colocalization of 5-HT1AR and lymphocytes was not found in the present study, while in a previous study [23] mRNA for this receptor was found in lymphocytes.
The localization of 5-HT1AR immunoreactivity to tryptase-positive cells, which constitute the majority of mast cells in the skin, might be of importance, since mediator release from these cells might take place through this receptor. A selective 5-HT1AR antagonist, WAY-100635, has been shown to suppress the effects of released mediators from visceral mast cells [24] . Other effects on mast cells and also melanocytes (see above) through these receptors might be trophic (see, for example, reference 25 for septal cholinergic neurons, length and number of branching points on neurites), or inhibitory, on apoptosis, which has been shown for neuronal cells [26] .
There was a wide expression of 5-HT2AR in both epidermal and dermal cells, which might support a role for this receptor in the inflammatory process. However, there was also high basal immunoreactivity for this receptor in control skin. Regarding inflammatory cells, it has been reported that different murine lymphoid cells have mRNA for 5-HT2AR [27] .
Immunoreactivity for 5-HT3R was seen at high intensity in the basal epidermal layer and also in cells in the acrosyringia, which supports previous findings that proliferating keratinocytes are sensitive to 5-HT. Maurer et al. [28] have reported that 5-HT stimulates proliferation of murine epidermal keratinocytes. In addition, there have been reports of 5-HT3R expression at the mRNA level in the border zones of epithelial tissue, such as regions of active epithelial-mesenchymal interaction in the rat, indicating a role for 5-HT3R in the process of secondary induction [29] .
In conclusion, the different distribution of 5-HT receptors in human skin indicates a plasticity in the effects of 5-HT, and especially of 5-HT1AR, in allergic contact eczematous skin.
